Docetaxel Combined With Cisplatin as First Line in Patients With Metastatic Non-small Cell Lung Cancer

Summary

This is a phase II, open-label clinical study prospectively enrolling 40 metastatic patients with non small cell lung cancer. The study will enroll patients at King Abdulaziz Medical City, Riyadh. Sub-sites will be open for patient accrual in selected centers in the Kingdom.

Timeline

Start

2009-03

Primary completion

2016-08

Completion

2016-08

Outcome

Outcome not reported

Stopped (Enrollment): “Difficulty in enrolling patients”

Drugs

Indications